Overview


According to FutureWise analysis, the market for Anti-Inflammatory Therapeutics is estimated to be US$ 90.83 billion in 2023 and is expected to reach US$ 152.82 billion by 2031 at a CAGR of 6.70% over the forecast period of 2023-2031.

Anti-inflammatory therapeutics constitute a diverse range of medications and treatments specifically designed to combat inflammation within the body. Inflammation is a fundamental immune response arising from injury, infection, or other forms of tissue irritation. However, when inflammation becomes prolonged or excessive, it can lead to chronic health conditions. Among the primary classes of anti-inflammatory therapeutics are steroidal and non-steroidal drugs. Steroidal anti-inflammatory drugs, also known as corticosteroids, emulate the action of naturally occurring hormones like cortisol. They are highly potent agents in suppressing inflammation and are frequently employed for their swift impact. Examples of corticosteroids include prednisone, dexamethasone, and hydrocortisone.

Non-steroidal anti-inflammatory drugs (NSAIDs) operate by inhibiting enzymes known as COX-1 and COX-2, which play a pivotal role in the production of prostaglandins, critical mediators of inflammation. NSAIDs are widely used for relieving pain, reducing fever, and controlling inflammation. Common examples encompass aspirin, ibuprofen, and naproxen. Recently, biologic response modifiers, commonly called biologics, have emerged as a distinctive class of drugs targeting specific molecules involved in the immune response. They are instrumental in managing conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Biologics include agents like adalimumab, infliximab, and etanercept.

FutureWise Market Research has published a report that provides an insightful analysis of Anti-Inflammatory Therapeutics Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Anti-Inflammatory Therapeutics Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Pfizer Inc.
  • AbbVie Inc.
  • Johnson and Johnson
  • GlaxoSmithKline plc
  • MerckCo., Inc.
  • Novartis AG
  • F. Hoffmann-La Roche AG
  • Eli Lily and Company
  • AstraZeneca PLC.
  • Amgen Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Anti-Inflammatory Therapeutics Market

  • In February 2021, AbbVie announced that the U.S. Food and Drug Administration (FDA) authorized HUMIRA (adalimumab) to treat ulcerative colitis in paediatric patients aged five years and older with moderate to highly active symptoms.

The rising prevalence of chronic inflammatory ailments like rheumatoid arthritis, osteoarthritis, and inflammatory bowel diseases demands anti-inflammatory therapeutics, which drive the market. As the senior population grows, the disease burden of age-related inflammatory conditions also rises, creating a high demand for anti-inflammatory treatments. Advancements in treatment modalities and therapeutics are leading to market growth. The government is organizing campaigns to raise awareness about the consequences of untreated inflammation and improve diagnostic techniques so that the treatment can be done on time, thus driving the market. Public-private organizations are raising funds for detailed research and development, creating an environment for the key players to work on innovative thoughts for launching products related to this market and bolstering the market's revenue growth. The development of biological drugs and targeted therapies offers more disease-specific and effective treatment options, fuelling the market growth.

However, adverse effects related to the drugs, especially in long-term use of high doses, can hamper the market growth. Limited accessibility in the developing regions and affordability of anti-inflammatory therapeutics hinder market growth. Using alternative therapies or complementary medicine approaches for managing inflammation declines the market growth.

By Indication

  • Arthritis
    • Rheumatoid Arthritis
    • Osteoarthritis
    • Ankylosing Spondylitis
    • Psoriatic Arthritis
    • Gout
  • Respiratory diseases
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
  • Multiple Sclerosis
  • Psoriasis
  • Inflammatory bowel disease
    • Crohn's Disease
    • Ulcerative Colitis
  • Other Inflammatory Diseases

By Drug Class

  • Anti-inflammatory Biologics
  • Non-Steroidal Anti-inflammatory drugs (NSAIDs)
  • Corticosteroids

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the significant rise in patients with psoriasis and irritable bowel. High expenditure on the healthcare industry and well-established healthcare infrastructure in this region are propelling the market. In addition, the government is raising funds to increase research and development in this field so more innovative treatment interventions and therapies can be discovered, propelling the market in this region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Anti-Inflammatory Therapeutics Market By Indication, By Drug Class and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections, which are represented in the format of data sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors, which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Anti-Inflammatory Therapeutics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Anti-Inflammatory Therapeutics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Anti-Inflammatory Therapeutics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Anti-Inflammatory Therapeutics Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Arthritis
         1.1. Rheumatoid Arthritis
         1.2. Osteoarthritis
         1.3. Ankylosing Spondylitis
         1.4. Psoriatic Arthritis
         1.5. Gout
        2. Respiratory diseases
         2.1. Asthma
         2.2. Chronic obstructive pulmonary disease (COPD)
        3. Multiple sclerosis
        4. Psoriasis
        5. Inflammatory bowel disease
         5.1. Crohn's Disease
         5.2. Ulcerative Colitis
        6. Other inflammatory diseases

  • 8.   Anti-Inflammatory Therapeutics Market, By Drug Class Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Anti-inflammatory Biologics
        2. Non-Steroidal Anti-inflammatory drugs (NSAIDs)
        3. Corticosteroids

  • 9.   North America Anti-Inflammatory Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Anti-Inflammatory Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Anti-Inflammatory Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Anti-Inflammatory Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Pfizer Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. AbbVie Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Johnson and Johnson
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. GlaxoSmithKline plc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. MerckCo., Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Novartis AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. F. Hoffmann-La Roche AG
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Eli Lily and Company
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. AstraZeneca PLC.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Amgen Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients